Therefore, we performed a meta-analysis of all eligible case-control studies with prostate cancer risk and aimed to reveal a more precise relationship between ESR1 gene polymorphisms and prostate cancer susceptibility. This evidence concerns the gene ESR1 and prostate cancer.